|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation Volume 8, Number 8, August 2002 Research DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective against H5N1 Challenge Infection in MiceSuzanne L. Epstein,* Terrence M. Tumpey,† Julia A. Misplon,* Chia-Yun
Lo,* Lynn A. Cooper, ‡ Kanta Subbarao,‡ Mary Renshaw,‡ Suryaprakash Sambhara,‡
and Jacqueline M. Katz‡ |
||
|
Back to article | |
Figure 1. DNA vaccination induces T-cell responses. a. Enzyme-linked immuno spot (ELISPOT) assay for interferon-g (IFN-g) secreting cells. Mice were immunized three times with A/NP+A/M or influenza B nucleoprotein DNA (B/NP DNA) intramuscularly. Spleen cells were analyzed by ELISPOT, using peptides at 1 µg/mL or A/PR/8 live virus. Results are the mean of three experiments. No response to A/PR/8 virus occurred in one experiment. Concanavalin A (Con A) responses: A/NP+A/M groups, >274 for all experiments; B/NP groups, >329 for all experiments. b. Cytotoxic T-cell assay. Mice were vaccinated as above or with live A/PR/8 virus given on the day of the second DNA injection. Spleens were harvested 2½ weeks after the third DNA injection. Spleen cells were restimulated in vitro with live A/PR/8 or B/AA. After 7 days of culture, restimulated effector cells at various ratios were mixed with P815 target cells infected with A/PR/8 or B/AA, and lactate dehydrogenase (LDH) release measured. |
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
This page last reviewed July 9, 2002 |
|
Emerging
Infectious Diseases Journal |
|